A redox-sensitive micelle-like nanoparticle self-assembled from amphiphilic adriamycin-human serum albumin conjugates for tumor targeted therapy

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Chen, Lin ^a   Chen, Feng ^b   Zhao, Mengxin ^c   Zhu, Xiandi ^c   Ke, Changhong ^c   Yu, Jiangming ^d   Yan, Zhiqiang ^e   Zhang, Fulei ^c   Sun, Yun ^c   Chen, Di ^c   Jiang, Cheng ^c   Zhao, Xianxian ^b   Gao, Yong ^a   Guo, Shangjing ^c   Li, Wei ^c  

^a First Affiliated Hospital of Fourth Military Medical University   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOPHILE; COPOLYMER; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; GLUTATHIONE; HUMAN SERUM ALBUMIN; HYDRAZIDE DERIVATIVE; NANOPARTICLE; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DISULFIDE BOND; DRUG CONJUGATION; DRUG RELEASE; DRUG SYNTHESIS; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; HYDROPHOBICITY; IC50; MALE; MICELLE; MOUSE; NONHUMAN; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG SCREENING; METABOLISM; NUDE MOUSE; PATHOLOGY; PROCEDURES; STOMACH NEOPLASMS; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; SERUM ALBUMIN; STOMACH NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84930641811     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/987404     Document Type: Article

References (35)

1. C. E. Myers, W. P. McGuire, R. H. Liss, I. Ifrim, K. Grotzinger, and R. C. Young, "Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response", Science, vol. 197, no. 4299, pp. 165-167, 1977.
2. W. Li, J. Li, J. Gao et al., "The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumors", Biomaterials, vol. 32, no. 15, pp. 3832-3844, 2011.
3. G. Joshi, R. Sultana, J. Tangpong et al., "Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain", Free Radical Research, vol. 39, no. 11, pp. 1147-1154, 2005.
4. H.-C. Yen, T. D. Oberley, S. Vichitbandha, Y.-S. Ho, and D. K. St. Clair, "The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice", The Journal of Clinical Investigation, vol. 98, no. 5, pp. 1253-1260, 1996.
5. K. A. Janes, M. P. Fresneau, A. Marazuela, A. Fabra, and M. J. Alonso, "Chitosan nanoparticles as delivery systems for doxorubicin", Journal of Controlled Release, vol. 73, no. 2-3, pp. 255-267, 2001.
6. J.-Z. Du, X.-J. Du, C.-Q. Mao, and J. Wang, "Tailor-Made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery", Journal of the American Chemical Society, vol. 133, no. 44, pp. 17560-17563, 2011.
7. S. Dreis, F. Rothweiler, M. Michaelis, J. Cinatl Jr., J. Kreuter, and K. Langer, "Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles", International Journal of Pharmaceutics, vol. 341, no. 1-2, pp. 207-214, 2007.
8. K. Langer, S. Balthasar, V. Vogel, N. Dinauer, H. Von Briesen, and D. Schubert, "Optimization of the preparation process for human serum albumin (HSA) nanoparticles", International Journal of Pharmaceutics, vol. 257, no. 1-2, pp. 169-180, 2003.
9. M. J. Hawkins, P. Soon-Shiong, and N. Desai, "Protein nanoparticles as drug carriers in clinical medicine", Advanced Drug Delivery Reviews, vol. 60, no. 8, pp. 876-885, 2008.
10. W. Li, S. Feng, and Y. Guo, "Tailoring polymeric micelles to optimize delivery to solid tumors", Nanomedicine, vol. 7, no. 8, pp. 1235-1252, 2012.
11. S. Cecco, M. Aliberti, P. Baldo, E. Giacomin, and R. Leone, "Safety and efficacy evaluation of albumin-bound paclitaxel", Expert Opinion on Drug Safety, vol. 13, no. 4, pp. 511-520, 2014.
12. F. Kratz, "Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles", Journal of Controlled Release, vol. 132, no. 3, pp. 171-183, 2008.
13. K. Wosikowski, E. Biedermann, B. Rattel et al., "In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells", Clinical Cancer Research, vol. 9, no. 5, pp. 1917-1926, 2003.
14. K. M. Osadnik and K. Jelonek, "The influence of conjugates on their functionality in the therapy of solid tumors", Acta Poloniae Pharmaceutica, vol. 70, no. 3, pp. 379-386, 2013.
15. W. Li, H.-F. Wei, H. Li, J. Gao, S.-S. Feng, and Y.-J. Guo, "Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology", Nanomedicine, vol. 9, no. 16, pp. 2587-2606, 2014.
16. R. Lehner, X. Wang, M. Wolf, and P. Hunziker, "Designing switchable nanosystems for medical application", Journal of Controlled Release, vol. 161, no. 2, pp. 307-316, 2012.
17. P. Kuppusamy, H. Li, G. Ilangovan et al., "Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels", Cancer Research, vol. 62, no. 1, pp. 307-312, 2002.
18. F. H. Meng, W. E. Hennink, and Z. Y. Zhong, "Reductionsensitive polymers and bioconjugates for biomedical applications", Biomaterials, vol. 30, no. 12, pp. 2180-2198, 2009.
19. P. Kuppusamy, M. Afeworki, R. A. Shankar et al., "In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model", Cancer Research, vol. 58, no. 7, pp. 1562-1568, 1998.
20. C. Cui, Y.-N. Xue, M. Wu et al., "Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles", Biomaterials, vol. 34, no. 15, pp. 3858-3869, 2013.
21. H. He, H. Kuang, L. Yan et al., "Areduction-sensitive carrier system using mesoporous silica nanospheres with biodegradable polyester as caps", Physical Chemistry Chemical Physics, vol. 15, no. 34, pp. 14210-14218, 2013.
22. A. Russo, W. De Graff, N. Friedman, and J. B. Mitchell, "Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential responses to chemotherapy drugs", Cancer Research, vol. 46, no. 6, pp. 2845-2848, 1986.
23. S. Bauhuber, C. Hozsa, M. Breunig, and A. Göpferich, "Delivery of nucleic acids via disulfide-based carrier systems", Advanced Materials, vol. 21, no. 32-33, pp. 3286-3306, 2009.
24. L. P. Lv, J. P. Xu, X. S. Liu, G. Y. Liu, X. Yang, and J. Ji, "Disulfidecrosslinked biomimetic micelles: formation, thiol reactivity and cytotoxicity behavior", Macromolecular Chemistry and Physics, vol. 211, no. 21, pp. 2292-2300, 2010.
25. H. Sun, F. Meng, R. Cheng, C. Deng, and Z. Zhong, "Reductionsensitive degradable micellar nanoparticles as smart and intuitive delivery systems for cancer chemotherapy", ExpertOpinion on Drug Delivery, vol. 10, no. 8, pp. 1109-1122, 2013.
26. C. Cui, Y.-N. Xue, M. Wu et al., "Poly (L-aspartamide)-based reduction-sensitive micelles as nanocarriers to improve doxorubicin content in cell nuclei and to enhance antitumor activity", Macromolecular Bioscience, vol. 13, no. 8, pp. 1036-1047, 2013.
27. Y. Gao, L. Chen, Z. Zhang, Y. Chen, and Y. Li, "Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticles", Biomaterials, vol. 32, no. 6, pp. 1738-1747, 2011.
28. G. Cheng, Y. He, L. Xie et al., "Development of a reductionsensitive diselenide-conjugated oligoethylenimine nano particulate system as a gene carrier", International Journal of Nanomedicine, vol. 7, pp. 3991-4006, 2012.
29. L. Zhang, H. Xue, Z. Cao, A. Keefe, J. Wang, and S. Jiang, "Multifunctional and degradable zwitterionic nanogels for targeted delivery, enhancedMRimaging, reduction-sensitive drug release, and renal clearance", Biomaterials, vol. 32, no. 20, pp. 4604-4608, 2011.
30. W. Li, S. Feng, and Y. Guo, "Block copolymer fornanomedicine", Nanomedicine, vol. 7, no. 3, pp. 383-392, 2012.
31. W. Li, H. Li, J. Li et al., "Self-assembled supramolecular nano vesicles for safe and highly efficient gene delivery to solid tumors", International Journal of Nanomedicine, vol. 7, pp. 4661-4677, 2012.
32. W. Li, H. Zhao, W. Qian et al., "Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles", Biomaterials, vol. 33, no. 21, pp. 5349-5362, 2012.
33. E. Ayano, M. Karaki, T. Ishihara, H. Kanazawa, and T. Okano, "Poly (N-isopropylacrylamide)-PLA and PLA blend nanoparticles for temperature-controllable drug release and intracellular uptake", Colloids and Surfaces B: Biointerfaces, vol. 99, pp. 67-73, 2012.
34. W. Li, L. Zhang, G. Zhang et al., "The finely regulating well-defined functional polymeric nanocarriers for anti-tumor immunotherapy", Mini-Reviews in Medicinal Chemistry, vol. 13, no. 5, pp. 643-652, 2013.
35. W. Li, M. Nakayama, J. Akimoto, and T. Okano, "Effect of block compositions of amphiphilic block copolymers on the physicochemical properties of polymeric micelles", Polymer, vol. 52, no. 17, pp. 3783-3790, 2011.